Overview
Dave Moore is a Senior Partner at ARCH Venture Partners [1], where the firm backs great science, partners with amazing people, and builds disruptive companies [2]. Moore held the position of Executive Vice President US Operations and Business Development and President of Novo Nordisk Inc. from January 2025 to April 2026 [4], following earlier roles at the same company as Executive Vice President Corporate Development [5] and Senior Vice President of Corporate Development [6]. Prior experience includes a position as Partner at Gurnet Point Capital [8] and CEO at Roivant Sciences [9]. Moore also served as Director on the Board of Directors for PhRMA [7]. Educational background includes a Bachelor's Degree in Biology from Towson University [13], an MBA in Marketing from Lehigh University College of Business [12], and a degree in Health Policy Excellence, Public Health & Policy from Jefferson Health [11].
Profile introduction
At Arch we Back Great Science. We Partner with Amazing People. We Build Disruptive Companies. Everywhere.
Career history
- Senior PartnerApr 2026 to presentARCH Venture Partners
- Executive Vice President US Operations and Business Development and President Novo Nordisk Inc.Jan 2025 to Apr 2026Novo Nordisk
- Executive Vice President Corporate DevelopmentMar 2023 to Jan 2025Novo Nordisk
- Senior Vice President of Corporate DevelopmentSep 2022 to Mar 2023Novo Nordisk
- Director Board of DirectorsDec 2024 to Feb 2026PhRMA
- PartnerMar 2020 to Sep 2022Gurnet Point Capital
- Vant CEOMay 2019 to Mar 2020Roivant Sciences
- Senior Vice President CommercialAug 2017 to May 2019Novo Nordisk
Education
- Health Policy Excellence, Public Health & Policy at Jefferson Health2009 - 2011
- MBA, MarketingLehigh University College of Business
- Bachelor's Degree, BiologyTowson University
This page shows public professional information only, each fact cited. Is this you? send a correction, or ask for removal within 24 hours, no questions asked.